Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo Controlled Trial of Greater Occipital Nerve Block for the Treatment of Migraine Attacks

NCT03159000 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03159000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo Controlled Trial of Greater Occipital Nerve Block for the Treatment of Migraine Attacks
Lead sponsor
Thomas Jefferson University
Phase
Phase 4
Overall status
Withdrawn
Start date
May 1, 2017
Completion date
June 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine